Women's Capital Corporation

Women's Capital Corporation was a specialty pharmaceutical company focused on the development and commercialization of reproductive health products. The company is most notable for developing Plan B, the first progestin-only emergency contraceptive to receive FDA approval in the United States. Founded by reproductive health advocates and experts, the organization sought to improve access to emergency contraception at a time when larger pharmaceutical firms avoided the sector due to political sensitivities. The company successfully navigated the regulatory process, leading to the commercial launch of Plan B in 1999. In 2003, the company was acquired by Barr Pharmaceuticals, which later became part of Teva Pharmaceutical Industries. Its legacy remains central to the history of women's reproductive rights and the availability of over-the-counter contraceptive options.